Gene · 10148
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome-wide N6-methyladenosine modification profiling of mRNAs during infection of Newcastle disease virus in chicken macrophages. | Virus Res | 2023 | 36326508 | PubTator, text mining | PubMed |
| Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis. | Biomol Biomed | 2023 | 36314719 | PubTator, text mining | PubMed |
| Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma. | Cancer Med | 2023 | 35668574 | PubTator, text mining | PubMed |
| Molecular and cellular factors determining the functional pleiotropy of cytokines. | FEBS J | 2023 | 35246947 | PubTator, text mining | PubMed |
| Low EBI3 Expression Promotes the Malignant Degree of Gastric Cancer. | Dis Markers | 2022 | 39291183 | PubTator, text mining | PubMed |
| Long noncoding and micro-RNA expression in a model of articular chondrocyte degeneration induced by stromal cell-derived factor-1. | Asian Biomed (Res Rev News) | 2022 | 37551168 | PubTator, text mining | PubMed |
| Palbociclib Enhances Migration and Invasion of Cancer Cells via Senescence-Associated Secretory Phenotype-Related CCL5 in Non-Small-Cell Lung Cancer. | J Oncol | 2022 | 37181790 | PubTator, text mining | PubMed |
| CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy. | Cancer Res Commun | 2022 | 36970051 | PubTator, text mining | PubMed |
| Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses. | Front Immunol | 2022 | 36818477 | PubTator, text mining | PubMed |
| Inflammatory Response in Patients With Crohn's Disease Compared With Ulcerative Colitis: Secondary Results of a Prospective Pilot Study. | Crohns Colitis 360 | 2022 | 36778516 | PubTator, text mining | PubMed |
| Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection. | Front Immunol | 2022 | 36741401 | PubTator, text mining | PubMed |
| Anticancer applications of phytochemicals in gastric cancer: Effects and molecular mechanism. | Front Pharmacol | 2022 | 36712679 | PubTator, text mining | PubMed |
| Leukemia-associated truncation of granulocyte colony-stimulating factor receptor impacts granulopoiesis throughout the life-course. | Front Immunol | 2022 | 36703974 | PubTator, text mining | PubMed |
| Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma. | Front Mol Biosci | 2022 | 36699699 | PubTator, text mining | PubMed |
| Macrophage scavenger receptors: Tumor support and tumor inhibition. | Front Oncol | 2022 | 36686729 | PubTator, text mining | PubMed |
| An integrative analysis of an lncRNA-mRNA competing endogenous RNA network to identify functional lncRNAs in uterine leiomyomas with RNA sequencing. | Front Genet | 2022 | 36685910 | PubTator, text mining | PubMed |
| Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression. | Front Immunol | 2022 | 36685556 | PubTator, text mining | PubMed |
| Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells. | Pharmaceuticals (Basel) | 2022 | 36678502 | PubTator, text mining | PubMed |
| Risk stratification of acute myeloid leukemia: Assessment using a novel prediction model based on ferroptosis-immune related genes. | Math Biosci Eng | 2022 | 36653976 | PubTator, text mining | PubMed |
| Integrative Methylome and Transcriptome Characterization Identifies SERINC2 as a Tumor-Driven Gene for Papillary Thyroid Carcinoma. | Cancers (Basel) | 2022 | 36612238 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10148/papers?page=14